Infographic: In Vitro Diagnostics Market Trends

The in vitro diagnostics (IVD) instruments, kits, reagents, and related supplies market is projected to grow to $74 billion by 2022.

Diagnostics providers are actively expanding into markets in developing countries, where there is a rising demand for quality healthcare services. However, stable in vitro diagnostics market growth is also expected in developed countries.

Topics: Diagnostics Kalorama Information Industry Insights

What’s New in Healthcare Markets? Kalorama Information Shares Its 2017 Research

Life sciences tends to be a source of competitive and investor interest, because of its potential role in fighting disease and increasing human health. We asked one of our publishers, Kalorama Information, to talk about its recently published market studies. The publisher noted the following areas of health care.

Topics: Diagnostics Healthcare Kalorama Information Industry Insights

5 Top Trends to Watch at AACC 2017

The American Association for Clinical Chemistry (AACC) is about to host its 69th Annual Scientific Meeting & Clinical Lab Expo, which will take place from July 31 through August 4.

According to the AACC website, the expo showcases a variety of cutting-edge technology with more than 200 new product introductions each year. With so much happening in the field, what should attendees expect to see?

Topics: Diagnostics Kalorama Information

15 Biotech Companies to Watch – New E-Book Now Available

Kalorama Information, a leading healthcare market research firm, just released a new e-book titled 15 Biotech Companies to Watch. This free resource covers a variety of innovative biotechnology companies and provides detailed information on novel products, emerging technologies, and M&A activity.

I caught up with Bruce Carlson, the Publisher of Kalorama Information, to hear more about the e-book and the biotechnology industry as a whole. Read the Q&A below for his unique insights into this rapidly evolving sector.

Topics: Biotechnology Kalorama Information

Electronic Medical Records: 7 Fast-Moving Trends to Watch

The $28 billion dollar electronic medical records (EMR) market is shaking up, nearly cracking, according to a new report by Kalorama Information, a leading healthcare market research firm.

The industry faces dissatisfaction among customers and IT staff shortages. Physicians are still not convinced EMRs reduce costs or improve patient care. On top of that, the Trump administration could usher in new policies, for better or worse.

Topics: Healthcare Kalorama Information Industry Insights

12 Leading Companies in Clinical Laboratory Services

Clinical laboratories are a critical component of health care. Approximately 80% of physicians’ diagnoses are a result of laboratory tests, according to Kalorama Information, a healthcare market research firm.

Common routine tests include cholesterol level tests, HIV tests, pap tests, pregnancy tests, and substance abuse tests. Clinical lab testing is also used to monitor diseases and drug treatments. Specialty testing, which is often more costly, may include genetics, immunology, oncology, endocrinology, and other segments.

Topics: Diagnostics Kalorama Information Industry Insights

3 Life Sciences Industry Reports by Kalorama Information

Kalorama Information provides life sciences industry research for leading drug, diagnostic, and medical device companies. Kalorama uses expert healthcare analysts who are highly knowledgeable and adept at discovering current trends. This publisher is regularly cited as a credible source by major news outlets such as The Wall Street Journal, Associated Press, The New York Times, Genetic Engineering News, Contract Pharma, and Becker’s Hospital Review.

This year, Kalorama Information has released a number of new market research reports on key diagnostics and medical device industries. Three major reports are profiled below.

Topics: Diagnostics Medical Devices Kalorama Information Industry Insights

Trump Will Find Reducing Drug Prices a Difficult Task

President Donald Trump’s stated goal of lowering drug prices won’t be easy. The President told drugmakers at a White House meeting that prices were “astronomical” and hinted at negotiating with Medicare and reducing regulation on new drugs. Congress has also proposed more generic drugs as a way of saving on costs.

While lower drug prices is an admirable goal, an across-the-board reduction of pharmaceutical prices will face many obstacles and most likely would not happen, according to our research at Kalorama Information. If somehow, Congress and the administration were able to achieve a reduction, it might impair the creation of new drugs.

Topics: Pharmaceuticals Kalorama Information Industry Insights

Retail Health Clinics Poised for Growth in 2017

Retail clinic locations have increased 38 percent in the last five years, according to Kalorama Information, a leading publisher of healthcare market research. Retail clinics are positioned for significant growth in the future, as patients continue to seek out convenient, low-cost healthcare services.

Because doctor's offices are usually only open during business hours on weekdays, it can often be challenging to make an appointment, take time off work, and sit in the waiting room before being seen by a medical professional. In contrast, retail clinics offer walk-in services seven days a week, including evenings and weekends.

Topics: Healthcare Kalorama Information

9 Leading Companies in Direct-to-Consumer Genetic Testing

As patients take a more proactive role in their own health care, direct-to-consumer (DTC) laboratory testing is becoming increasingly popular. DTC genetic tests allow consumers to access information about their genetics without necessarily involving healthcare professionals in the process. 

A number of established and emerging companies are competing in this growing market. Kalorama Information, a healthcare market research firm owned by MarketResearch.com, recently profiled a variety of prominent market participants in its report The Market for Direct-to-Consumer Genetic Testing and Routine Laboratory Testing. This blog post highlights 9 of these companies that are among the leaders in the industry.

Topics: Diagnostics Healthcare Kalorama Information